PHARMASGP HOLDING SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.4 EUR | -0.88% |
|
+0.90% | -0.44% |
| Apr. 29 | PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 18 | PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 | CI |
| Sales 2024 * | 109M 118M | Sales 2025 * | 116M 126M | Capitalization | 269M 291M |
|---|---|---|---|---|---|
| Net income 2024 * | 18M 19.52M | Net income 2025 * | 19M 20.61M | EV / Sales 2024 * | 2.69 x |
| Net Debt 2024 * | 24.7M 26.79M | Net cash position 2025 * | 22.95M 24.89M | EV / Sales 2025 * | 2.12 x |
| P/E ratio 2024 * |
15.2
x | P/E ratio 2025 * |
14.1
x | Employees | 89 |
| Yield 2024 * |
3.3% | Yield 2025 * |
3.06% | Free-Float | 18.52% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.88% | ||
| 1 week | +0.90% | ||
| 1 month | -4.27% | ||
| 3 months | -2.18% | ||
| 6 months | +19.47% | ||
| Current year | -0.44% |
1 week
22.20
23.60
1 month
21.8023.60
Current year
19.8524.50
1 year
17.7029.50
3 years
17.7029.60
5 years
14.4036.00
10 years
14.4036.00
| Managers | Title | Age | Since |
|---|---|---|---|
Natalie Weigand
CEO | Chief Executive Officer | 43 | 16-12-31 |
Michael Rudolf
DFI | Director of Finance/CFO | 50 | 16-12-31 |
Lara Mögenburg
HRO | Human Resources Officer | - | 20-02-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Axel Rebien
BRD | Director/Board Member | 52 | 20-05-31 |
Clemens Fischer
CHM | Chairman | 49 | 20-03-03 |
| Director/Board Member | 43 | 20-03-03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 22.4 | -0.88% | 730 |
| 24-05-30 | 22.6 | +0.89% | 1,440 |
| 24-05-29 | 22.4 | -0.88% | 986 |
| 24-05-28 | 22.6 | -3.42% | 716 |
| 24-05-27 | 23.4 | +5.41% | 895 |
Delayed Quote Xetra, May 31, 2024 at 11:36 am EDT
More quotes
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products.
Sector
Pharmaceuticals
Calendar
2024-06-25
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.4
EUR
Average target price
37
EUR
Spread / Average Target
+65.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.44% | 291M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- PSG Stock
